Fate Therapeutics Inc(FATE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

FATE Fate Therapeutics Inc

交易中 03-24 10:43:08 EDT

1.14

-0.01

-0.87%

最高1.15	最低1.11	成交量25.94万
今开1.13	昨收1.15	日振幅3.48%
总市值1.33亿	流通市值1.15亿	总股本1.16亿
成交额29.24万	换手率0.26%	流通股本1.01亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"FATE","market":"US","secType":"STK","nameCN":"Fate Therapeutics Inc","latestPrice":1.14,"timestamp":1774363383545,"preClose":1.15,"halted":0,"volume":259398,"delay":0,"changeRate":-0.008695652173913052,"floatShares":100797117,"shares":116263459,"eps":-1.149999,"marketStatus":"交易中","change":-0.01,"latestTime":"03-24 10:43:08 EDT","open":1.13,"high":1.15,"low":1.11,"amount":292394.8263492,"amplitude":0.034783,"askPrice":1.14,"askSize":21690,"bidPrice":1.13,"bidSize":4533,"shortable":3,"etf":0,"ttmEps":-1.149999,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1774382400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1380600000000,"exchange":"NASDAQ","adjPreClose":1.15,"preHourTrading":{"tag":"盘前","latestPrice":1.15,"preClose":1.15,"latestTime":"09:18 EDT","volume":959,"amount":1129.3998191,"timestamp":1774358304488,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":1.1965,"preClose":1.15,"latestTime":"19:43 EDT","volume":25947,"amount":29905.0271,"timestamp":1774309406220,"change":0.0465,"changeRate":0.040435,"amplitude":0.040435},"volumeRatio":0.750508,"impliedVol":0.3175,"impliedVolPercentile":0.0677},"requestUrl":"/m/hq/s/FATE","defaultTab":"news","newsList":[{"id":"1190381786","title":"Fate Therapeutics Inc：预计运营资金可支撑至2027年底，现金及投资总额达2.05亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1190381786","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190381786?lang=zh_cn&edition=full","pubTime":"2026-02-26 22:12","pubTimestamp":1772115126,"startTime":"0","endTime":"0","summary":"生物技术公司Fate Therapeutics Inc宣布，其现有资金储备足以维持公司运营至2027年底。公司目前持有现金、现金等价物及各类投资合计2.05亿美元，为后续细胞疗法研发提供了坚实财务基础。这一资金规划将支持公司推进包括CAR-NK和iPSC衍生细胞疗法在内的多项临床前及临床阶段项目，同时保障企业在新药研发关键阶段的持续投入。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FATE","BK4139"],"gpt_icon":0},{"id":"2584573169","title":"Fate Therapeutics, Inc.盘中异动 大幅拉升5.86%报1.030美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584573169","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584573169?lang=zh_cn&edition=full","pubTime":"2025-11-18 22:45","pubTimestamp":1763477136,"startTime":"0","endTime":"0","summary":"北京时间2025年11月18日22时45分，Fate Therapeutics, Inc.股票出现波动，股价急速拉升5.86%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Olema Pharmaceuticals, Inc.、Can Fite Biopharma Ltd、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大，Can Fite Biopharma Ltd、Clearmind Medicine Inc.、Aspire Biopharma Holdings, Inc.较为活跃，换手率分别为1320.19%、769.70%、276.33%，振幅较大的相关个股有Olema Pharmaceuticals, Inc.、Clearmind Medicine Inc.、Can Fite Biopharma Ltd，振幅分别为72.30%、35.46%、31.77%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111822453697716187&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111822453697716187&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","FATE","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"1193909869","title":"Fate Therapeutics Inc：Wedbush将评级从中性上调至跑赢大盘；将目标价格从5美元提升至7美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1193909869","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193909869?lang=zh_cn&edition=full","pubTime":"2025-10-27 18:51","pubTimestamp":1761562270,"startTime":"0","endTime":"0","summary":"Fate Therapeutics Inc：Wedbush将评级从中性上调至跑赢大盘；将目标价格从5美元提升至7美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FATE"],"gpt_icon":0},{"id":"2573902601","title":"Fate Therapeutics, Inc.盘中异动 股价大涨5.79%报1.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2573902601","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573902601?lang=zh_cn&edition=full","pubTime":"2025-10-06 21:36","pubTimestamp":1759757810,"startTime":"0","endTime":"0","summary":"北京时间2025年10月06日21时36分，Fate Therapeutics, Inc.股票出现波动，股价大幅拉升5.79%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Spruce Biosciences, Inc.、Leap Therapeutics, Inc.、Moolec Science Sa C/Wts 涨幅较大，Spruce Biosciences, Inc.、Palisade Bio, Inc.、Leap Therapeutics, Inc.较为活跃，换手率分别为1831.98%、71.14%、21.45%，振幅较大的相关个股有Spruce Biosciences, Inc.、Leap Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为70.52%、23.19%、11.48%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251006213650a4552bc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251006213650a4552bc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FATE","BK4007","BK4139","BK4539","LENZ"],"gpt_icon":0},{"id":"2572503811","title":"Fate Therapeutics, Inc.盘中异动 急速跳水5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2572503811","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572503811?lang=zh_cn&edition=full","pubTime":"2025-10-02 21:57","pubTimestamp":1759413450,"startTime":"0","endTime":"0","summary":"北京时间2025年10月02日21时57分，Fate Therapeutics, Inc.股票出现波动，股价快速下跌5.52%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。其相关个股中，Aspire Biopharma Holdings, Inc.、Taysha Gene Therapies, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Aspire Biopharma Holdings, Inc.、Kazia Therapeutics Limited、Dermata Therapeutics, Inc.较为活跃，换手率分别为634.13%、155.78%、63.94%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Aspire Biopharma Holdings, Inc.、Taysha Gene Therapies, Inc.，振幅分别为32.00%、28.10%、19.50%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251002215731a6ab3487&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251002215731a6ab3487&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FATE","LENZ","BK4007","BK4539","BK4139"],"gpt_icon":0},{"id":"2518149227","title":"Fate Therapeutics, Inc.盘中异动 早盘快速下挫5.66%报0.953美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518149227","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518149227?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:50","pubTimestamp":1741614611,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时50分，Fate Therapeutics, Inc.股票出现异动，股价大幅下挫5.66%。截至发稿，该股报0.953美元/股，成交量11.0385万股，换手率0.10%，振幅2.97%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2739.31%、617.86%、95.77%，振幅较大的相关个股有Scisparc Ltd.、Impact Biomedical, Inc.、Trevi Therapeutics, Inc.，振幅分别为40.24%、28.59%、25.35%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021501196403af3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021501196403af3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FATE","LENZ"],"gpt_icon":0},{"id":"2518788289","title":"Fate Therapeutics, Inc.2024财年实现净利润-1.86亿美元，同比减少15.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518788289","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518788289?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:00","pubTimestamp":1741536051,"startTime":"0","endTime":"0","summary":"3月10日，Fate Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-1.86亿美元，同比减少15.53%；其中营业收入为13.63百万美元，同比减少78.55%，每股基本收益为-1.64美元。机构评级：截至2025年3月10日，当前有11家机构对Fate Therapeutics, Inc.目标价做出预测，其中目标均价为6.64美元，其中最低目标价为3.00美元，最高目标价为12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000116abf1752b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000116abf1752b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FATE","LENZ"],"gpt_icon":0},{"id":"2517758162","title":"Stifel：维持Fate Therapeutics(FATE.US)评级，由持有调整至持有评级, 目标价由5.00美元调整至3.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517758162","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517758162?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:05","pubTimestamp":1741277144,"startTime":"0","endTime":"0","summary":"Stifel：维持Fate Therapeutics(FATE.US)评级，由持有调整至持有评级, 目标价由5.00美元调整至3.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/07000548577051.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["FATE","LENZ"],"gpt_icon":0},{"id":"2517734989","title":"Fate Therapeutics(FATE.US)：2024年Q4财报实现营收186万美元，前值为167.6万美元，预期值为157万美元；每股收益为-0.44美元，前值为-0.45美元，预期值为-0.43美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517734989","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517734989?lang=zh_cn&edition=full","pubTime":"2025-03-06 07:18","pubTimestamp":1741216725,"startTime":"0","endTime":"0","summary":"Fate Therapeutics(FATE.US)：2024年Q4财报实现营收186万美元，前值为167.6万美元，预期值为157万美元；每股收益为-0.44美元，前值为-0.45美元，预期值为-0.43美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/06071848551671.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","FATE"],"gpt_icon":0},{"id":"1129075237","title":"Fate Therapeutics 2024年第四季度GAAP每股收益$(0.44) 不及预期$(0.43)，销售额$1.860 不及预期$1.416百万","url":"https://stock-news.laohu8.com/highlight/detail?id=1129075237","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129075237?lang=zh_cn&edition=full","pubTime":"2025-03-06 05:11","pubTimestamp":1741209061,"startTime":"0","endTime":"0","summary":"Fate Therapeutics报告2024年第四季度每股亏损$，未能达到分析师一致预期的$，低于预期2.33%。公司报告季度销售额为$1.860，未达到分析师一致预期的$1.416百万，低于预期100%。与去年同期销售额$1.676百万相比，下降了100%。以上内容来自Benzinga Earnings专栏，原文如下：Fate $Therapeutics$  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 2.33 percent. This is a 2.22 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $1.860 which missed the analyst consensus estimate of $1.416 million by 100.00","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Fate Therapeutics 2024年第四季度GAAP每股收益$(0.44) 不及预期$(0.43)，销售额$1.860 不及预期$1.416百万","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FATE"],"gpt_icon":0},{"id":"2517794153","title":"Fate Therapeutics, Inc.盘中异动 早盘大幅下挫5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517794153","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517794153?lang=zh_cn&edition=full","pubTime":"2025-03-06 00:24","pubTimestamp":1741191843,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日00时24分，Fate Therapeutics, Inc.股票出现波动，股价大幅下跌5.05%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.12%。其相关个股中，Chimerix, Inc.、Nutriband Inc C/Wts 、Silexion Therapeutics Corp涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为904.73%、293.48%、278.75%，振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为82.59%、54.27%、41.26%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306002403963af686&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306002403963af686&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FATE","LENZ","BK4139"],"gpt_icon":0},{"id":"2516373366","title":"Fate Therapeutics, Inc.盘中异动 急速下挫5.36%报1.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516373366","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516373366?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:02","pubTimestamp":1741014147,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时02分，Fate Therapeutics, Inc.股票出现异动，股价快速下跌5.36%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Entero Therapeutics Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为975.81%、123.66%、98.58%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.，振幅分别为163.15%、70.53%、48.34%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230227a25d4965&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230227a25d4965&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FATE","BK4139"],"gpt_icon":0},{"id":"2514320226","title":"Fate Therapeutics, Inc.盘中异动 早盘股价大跌5.50%报1.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514320226","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514320226?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:31","pubTimestamp":1740753086,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时31分，Fate Therapeutics, Inc.股票出现波动，股价快速下跌5.50%。截至发稿，该股报1.03美元/股，成交量5.7451万股，换手率0.05%，振幅3.67%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822312698967993&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822312698967993&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FATE","BK4139"],"gpt_icon":0},{"id":"2514317223","title":"Fate Therapeutics, Inc.盘中异动 股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514317223","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514317223?lang=zh_cn&edition=full","pubTime":"2025-02-28 03:34","pubTimestamp":1740684867,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日03时34分，Fate Therapeutics, Inc.股票出现波动，股价快速跳水5.17%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Pepgen Inc.、Alpha Tau Medical Ltd C/Wts 、Ibio, Inc.涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1904.24%、330.55%、183.83%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation，振幅分别为86.14%、67.32%、55.84%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022803342898954802&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022803342898954802&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FATE","BK4139"],"gpt_icon":0},{"id":"2514869287","title":"Fate Therapeutics, Inc.盘中异动 下午盘大幅跳水5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514869287","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514869287?lang=zh_cn&edition=full","pubTime":"2025-02-27 02:56","pubTimestamp":1740596203,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日02时56分，Fate Therapeutics, Inc.股票出现波动，股价快速跳水5.69%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.71%。其相关个股中，Enveric Biosciences, Inc.、Renovaro Inc.、Nkgen Biotech Inc C/Wts 31/05/2028涨幅较大，Enveric Biosciences, Inc.、Aeon Biopharma, Inc.、Organovo Holdings, Inc.较为活跃，换手率分别为6511.90%、287.16%、255.94%，振幅较大的相关个股有Enveric Biosciences, Inc.、Renovaro Inc.、Organovo Holdings, Inc.，振幅分别为194.07%、78.53%、52.76%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022702564396317f81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022702564396317f81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FATE","BK4139"],"gpt_icon":0},{"id":"2513722757","title":"Fate Therapeutics, Inc.盘中异动 股价大跌5.56%报1.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513722757","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513722757?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:42","pubTimestamp":1740408139,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时42分，Fate Therapeutics, Inc.股票出现异动，股价大幅跳水5.56%。截至发稿，该股报1.34美元/股，成交量6.8867万股，换手率0.06%，振幅4.23%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242242199890f89c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242242199890f89c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FATE","LENZ","BK4139"],"gpt_icon":0},{"id":"2513299115","title":"Fate Therapeutics, Inc.盘中异动 早盘急速下挫5.17%报1.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513299115","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513299115?lang=zh_cn&edition=full","pubTime":"2025-02-21 23:07","pubTimestamp":1740150451,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日23时07分，Fate Therapeutics, Inc.股票出现波动，股价大幅下跌5.17%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Osr Holdings, Inc.、Osr Holdings Inc C/Wts 09/02/2028 、Nkgen Biotech, Inc.涨幅较大，Nkgen Biotech, Inc.、Aditxt, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为119.86%、95.38%、72.08%，振幅较大的相关个股有Osr Holdings, Inc.、Osr Holdings Inc C/Wts 09/02/2028 、Omega Therapeutics, Inc.，振幅分别为67.41%、57.50%、35.45%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221230731962b840d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221230731962b840d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FATE","LENZ"],"gpt_icon":0},{"id":"2512880744","title":"Fate Therapeutics, Inc.盘中异动 早盘股价大跌5.85%报1.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512880744","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512880744?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:31","pubTimestamp":1739975476,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时31分，Fate Therapeutics, Inc.股票出现异动，股价大幅下挫5.85%。截至发稿，该股报1.44美元/股，成交量3.4566万股，换手率0.03%，振幅0.33%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Osr Holdings, Inc.、Aditxt, Inc.、Citius Pharmaceuticals, Inc.涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Chemomab Therapeutics Ltd较为活跃，换手率分别为203.31%、201.46%、65.47%，振幅较大的相关个股有Allogene Therapeutics, Inc.、Azitra Inc、Opthea Limited，振幅分别为17.25%、11.29%、7.44%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223116988b3134&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223116988b3134&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FATE","LENZ"],"gpt_icon":0},{"id":"2512542165","title":"Fate Therapeutics, Inc.盘中异动 股价大涨6.69%报1.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512542165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512542165?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:30","pubTimestamp":1739889044,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时30分，Fate Therapeutics, Inc.股票出现波动，股价大幅拉升6.69%。截至发稿，该股报1.52美元/股，成交量4.9702万股，换手率0.04%，振幅0.00%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223044962796c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223044962796c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FATE","BK4139","LENZ"],"gpt_icon":0},{"id":"2511169186","title":"Fate Therapeutics, Inc.盘中异动 早盘急速上涨5.51%报1.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511169186","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511169186?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:31","pubTimestamp":1739543488,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时31分，Fate Therapeutics, Inc.股票出现波动，股价快速拉升5.51%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。其相关个股中，Moleculin Biotech, Inc.、Virpax Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Virpax Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为994.38%、358.66%、323.79%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Theratechnologies Inc.、Virpax Pharmaceuticals, Inc.，振幅分别为20.20%、18.33%、15.20%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422312896231b40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422312896231b40&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FATE","LENZ","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fatetherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0086},{"period":"1month","weight":-0.2123},{"period":"3month","weight":0.1773},{"period":"6month","weight":0.1386},{"period":"1year","weight":0.2583},{"period":"ytd","weight":0.1704}],"compareEarnings":[{"period":"1week","weight":-0.0204},{"period":"1month","weight":-0.0494},{"period":"3month","weight":-0.0474},{"period":"6month","weight":-0.0087},{"period":"1year","weight":0.1621},{"period":"ytd","weight":-0.0389}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Fate Therapeutics, Inc.于2007年4月27日在特拉华州注册成立，总部位于加利福尼亚州圣地亚哥。作为一家临床阶段的生物制药公司，该公司专注于开发现成的、多重工程、诱导多能干细胞（iPSC）衍生的细胞免疫疗法，旨在用于患者治疗。","yearOnYearQuotes":[{"month":1,"riseRate":0.538462,"avgChangeRate":0.049458},{"month":2,"riseRate":0.615385,"avgChangeRate":0.078089},{"month":3,"riseRate":0.461538,"avgChangeRate":-0.023177},{"month":4,"riseRate":0.583333,"avgChangeRate":0.001011},{"month":5,"riseRate":0.416667,"avgChangeRate":-0.020051},{"month":6,"riseRate":0.5,"avgChangeRate":0.003206},{"month":7,"riseRate":0.416667,"avgChangeRate":0.050198},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.024603},{"month":9,"riseRate":0.416667,"avgChangeRate":0.00072},{"month":10,"riseRate":0.25,"avgChangeRate":-0.091603},{"month":11,"riseRate":0.538462,"avgChangeRate":0.090829},{"month":12,"riseRate":0.538462,"avgChangeRate":0.045045}],"exchange":"NASDAQ","name":"Fate Therapeutics Inc","nameEN":"Fate Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Fate Therapeutics Inc(FATE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Fate Therapeutics Inc(FATE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Fate Therapeutics Inc,FATE,Fate Therapeutics Inc股票,Fate Therapeutics Inc股票老虎,Fate Therapeutics Inc股票老虎国际,Fate Therapeutics Inc行情,Fate Therapeutics Inc股票行情,Fate Therapeutics Inc股价,Fate Therapeutics Inc股市,Fate Therapeutics Inc股票价格,Fate Therapeutics Inc股票交易,Fate Therapeutics Inc股票购买,Fate Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Fate Therapeutics Inc(FATE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Fate Therapeutics Inc(FATE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}